litlas
Log inCreate account

Thomas W. Geisbert

Active 1990–2025

177
Papers
26,277
Citations
95
h-index
175
i10-index

Citations

Citations per year for Thomas W. Geisbert1991: 1 citations1992: 7 citations1993: 4 citations1994: 2 citations1995: 6 citations1996: 13 citations1997: 3 citations1998: 14 citations1999: 55 citations2000: 35 citations2001: 64 citations2002: 57 citations2003: 116 citations2004: 146 citations2005: 129 citations2006: 228 citations2007: 264 citations2008: 170 citations2009: 151 citations2010: 258 citations2011: 311 citations2012: 341 citations2013: 231 citations2014: 342 citations2015: 323 citations2016: 227 citations2017: 217 citations2018: 223 citations2019: 776 citations2020: 929 citations2021: 1,016 citations2022: 940 citations2023: 602 citations2024: 1,006 citations2025: 439 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,567 citing papers, 33.2% of this breakdownChina: 533 citing papers, 6.9% of this breakdownUnited Kingdom: 427 citing papers, 5.5% of this breakdownGermany: 374 citing papers, 4.8% of this breakdownCanada: 324 citing papers, 4.2% of this breakdownFrance: 300 citing papers, 3.9% of this breakdownIndia: 222 citing papers, 2.9% of this breakdownJapan: 175 citing papers, 2.3% of this breakdownSwitzerland: 173 citing papers, 2.2% of this breakdownItaly: 154 citing papers, 2% of this breakdownAustralia: 151 citing papers, 1.9% of this breakdownNetherlands: 147 citing papers, 1.9% of this breakdown
0%33.2%Other 28.3%

Institutions

Fields

  • Medicine75.4%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Immunology and Microbiology7.3%
  • Agricultural and Biological Sciences1.6%
  • Engineering1.6%
  • Environmental Science0.7%
  • Other2.3%

Topics

  • Viral Infections and Outbreaks Research12.8%
  • Viral Infections and Vectors10%
  • SARS-CoV-2 and COVID-19 Research9.4%
  • Viral gastroenteritis research and epidemiology4.7%
  • COVID-19 Clinical Research Studies3.9%
  • Mosquito-borne diseases and control3.3%
  • Other55.9%

Coauthors

All papers

Open in search
  1. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

    Authors: Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, J. Hendle, Anna Pustilnik, J.M. Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole L. Kallewaard, Kevin R. Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Markéta Řičicová, Lindsay DeVorkin, Caitlin Pritchard, Aoise O’Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney A. Cohen, John M. Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis J. Muñoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet D. Menachery, Kumari G. Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa K. Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart - Cell Reports 2022 cited by 464

  2. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

    Authors: Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett, Kathryn Westendorf, Julian Davies, Thomas P. Cujec, Christopher M. Wiethoff, Jamie L. Blackbourne, Beverly A. Heinz, Denisa Foster, Richard E. Higgs, Deepa Balasubramaniam, Lingshu Wang, Yi Zhang, Eun Sung Yang, Roza Bidshahri, Lucas Kraft, Yuri Hwang, Stefanie Žentelis, Kevin R. Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Samuel J. Hinshaw, Sean A. Tycho, Davide Pellacani, Ping Xiang, Krithika Muthuraman, Solmaz Sobhanifar, Marissa H. Piper, Franz J. Triana, J. Hendle, Anna Pustilnik, Andrew C. Adams, Shawn Berens, Ralph S. Baric, David R. Martinez, Robert W. Cross, Thomas W. Geisbert, Viktoriya Borisevich, Olubukola M. Abiona, Hayley M. Belli, Maren de Vries, Adil Mohamed, Meike Dittmann, Marie I. Samanovic, Mark J. Mulligan, Jory A. Goldsmith, Ching‐Lin Hsieh, Nicole V. Johnson, Daniel Wrapp, Jason S. McLellan, Bryan C. Barnhart, Barney S. Graham, John R. Mascola, Carl L. Hansen, Ester Falconer - Science Translational Medicine 2021 cited by 497

  3. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy

    Authors: Chad E. Mire, Benjamin A. Satterfield, Joan B. Geisbert, Krystle N. Agans, Viktoriya Borisevich, Lianying Yan, Yee‐Peng Chan, Robert W. Cross, Karla A. Fenton, Christopher C. Broder, Thomas W. Geisbert - Scientific Reports 2016 cited by 212

  4. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

    Authors: Steven M Jones, Heinz Feldmann, Ute Ströher, Joan B. Geisbert, Lisa Fernando, Allen Grolla, Hans-Dieter Klenk, Nancy J. Sullivan, Viktor E. Volchkov, Elizabeth A. Fritz, Kathleen M Daddario, Lisa E. Hensley, Peter B. Jahrling, Thomas W. Geisbert - Nature Medicine 2005 cited by 690

  5. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

    Authors: Ha V. Dang, Yee‐Peng Chan, Young‐Jun Park, Joost Snijder, Sofia Cheliout Da Silva, Bang K. Vu, Lianying Yan, Yan-Ru Feng, Barry Rockx, Thomas W. Geisbert, Chad E. Mire, Christopher C. Broder, David Veesler - Nature Structural & Molecular Biology 2019 cited by 118

  6. A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

    Authors: Thomas W. Geisbert, Kathryn Bobb, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Robert W. Cross, Abhishek N. Prasad, Karla A. Fenton, Hao Yu, Timothy Fouts, Christopher C. Broder, Antony S. Dimitrov - npj Vaccines 2021 cited by 93

  7. The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)

    Authors: Gary M. Zaucha, Peter B. Jahrling, Thomas W. Geisbert, James R. Swearengen, Lisa E. Hensley - Laboratory Investigation 2001 cited by 320

  8. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein

    Authors: Jinhui Dong, Robert W. Cross, Michael P. Doyle, Nurgun Kose, Jarrod J. Mousa, Edward J. Annand, Viktoriya Borisevich, Krystle N. Agans, Rachel E. Sutton, Rachel S. Nargi, Mahsa Majedi, Karla A. Fenton, Walter Reichard, Robin Bombardi, Thomas W. Geisbert, James E. Crowe - Cell 2020 cited by 81

  9. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death

    Authors: Robert W. Cross, Rong Xu, Demetrius Matassov, Stefan Hamm, Theresa Latham, Cheryl Gerardi, Rebecca M. Nowak, Joan B. Geisbert, Ayuko Ota‐Setlik, Krystle N. Agans, Amara Luckay, Susan E. Witko, Lena Soukieh, Daniel J. Deer, Chad E. Mire, Heinz Feldmann, Christian Happi, Karla A. Fenton, John H. Eldridge, Thomas W. Geisbert - Journal of Clinical Investigation 2019 cited by 79

  10. Lassa Fever in Post-Conflict Sierra Leone

    Authors: Jeffrey G. Shaffer, Donald S. Grant, John S. Schieffelin, Matthew L. Boisen, Augustine Goba, Jessica N. Hartnett, Danielle Levy, Rachael E. Yenni, Lina Moses, Mohammed Fullah, Momoh Mambo, Mbalu Fonnie, Richard Fonnie, Lansana Kanneh, Veronica Koroma, Kandeh Kargbo, Ottomassathien Darin, Ivana J Muncy, Abigail B. Jones, Megan M. Illick, Peter C. Kulakosky, Allyson M. Haislip, Christopher M. Bishop, Deborah H. Elliot, Bethany Brown, Zhu Hu, Kathryn M. Hastie, Kristian G. Andersen, Stephen Gire, Shervin Tabrizi, Ridhi Tariyal, Mathew Stremlau, Alex Matschiner, Darryl Sampey, Jennifer S. Spence, Robert W. Cross, Joan B. Geisbert, Onikepe Folarin, Christian Happi, Kelly R. Pitts, F. Jon Geske, Thomas W. Geisbert, Erica Ollmann Saphire, James E. Robinson, Russell B. Wilson, Pardis C. Sabeti, Lee A. Henderson, Sheik Humarr Khan, Daniel G. Bausch, Luis M. Branco, Robert F. Garry - PLoS neglected tropical diseases 2014 cited by 236

  11. Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody

    Authors: Thomas W. Geisbert, Chad E. Mire, Joan B. Geisbert, Yee‐Peng Chan, Krystle N. Agans, Friederike Feldmann, Karla A. Fenton, Zhongyu Zhu, Dimiter S. Dimitrov, Dana Scott, Katharine N. Bossart, Heinz Feldmann, Christopher C. Broder - Science Translational Medicine 2014 cited by 181

  12. Ebola

    Authors: Heinz Feldmann, Armand Sprecher, Thomas W. Geisbert - New England Journal of Medicine 2020 cited by 204

  13. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever

    Authors: J. Maximilian Fels, Daniel P. Maurer, Andrew S. Herbert, Ariel S. Wirchnianski, Olivia Vergnolle, Robert W. Cross, Dafna M. Abelson, Crystal L. Moyer, Akaash K. Mishra, Jennifer T. Aguilan, Ana I. Kuehne, Noel T. Pauli, Russell R. Bakken, Elisabeth K. Nyakatura, Jan Hellert, Gregory Quevedo, Leslie Lobel, Stephen Balinandi, Julius J. Lutwama, Larry Zeitlin, Thomas W. Geisbert, F.A. Rey, Simone Sidoli, Jason S. McLellan, Jonathan R. Lai, Zachary A. Bornholdt, John M. Dye, Laura M. Walker, Kartik Chandran - Cell 2021 cited by 93

  14. Combination therapy protects macaques against advanced Marburg virus disease

    Authors: Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Dafna M. Abelson, Do H. Kim, William S. Shestowsky, Lioudmila A. Campbell, Elaine Bunyan, Joan B. Geisbert, Karla A. Fenton, Larry Zeitlin, Danielle Porter, Thomas W. Geisbert - Nature Communications 2021 cited by 92

  15. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

    Authors: James E. Robinson, Kathryn M. Hastie, Robert W. Cross, Rachael E. Yenni, Deborah H. Elliott, Julie A. Rouelle, Chandrika B. Kannadka, Ashley A. Smira, Courtney E. Garry, Benjamin T. Bradley, Haini Yu, Jeffrey G. Shaffer, Matthew L. Boisen, Jessica N. Hartnett, Michelle Zandonatti, Megan M. Rowland, Megan L. Heinrich, Luis Martínez‐Sobrido, Benson Yee Hin Cheng, Juan Carlos de la Torre, Kristian G. Andersen, Augustine Goba, Mambu Momoh, Mohamed Fullah, Michael Gbakie, Lansana Kanneh, Veronica Koroma, Richard Fonnie, Simbirie Jalloh, Brima Kargbo, Mohamed Vandi, Momoh Gbetuwa, Ikponmwosa Odia, Danny Asogun, Peter O. Okokhere, Onikepe A. Follarin, John S. Schieffelin, Kelly R. Pitts, Joan B. Geisbert, Peter C. Kulakoski, Russell B. Wilson, Christian Happi, Pardis C. Sabeti, Sahr M. Gevao, Sheik Humarr Khan, Donald S. Grant, Thomas W. Geisbert, Erica Ollmann Saphire, Luis M. Branco, Robert F. Garry - Nature Communications 2016 cited by 183

  16. A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge

    Authors: Katharine N. Bossart, Barry Rockx, Friederike Feldmann, D Brining, Dana Scott, Rachel LaCasse, Joan B. Geisbert, Yanru Feng, Yee‐Peng Chan, Andrew C. Hickey, Christopher C. Broder, Heinz Feldmann, Thomas W. Geisbert - Science Translational Medicine 2012 cited by 160

  17. Ebola haemorrhagic fever

    Authors: Heinz Feldmann, Thomas W. Geisbert - The Lancet 2010 cited by 1,364

  18. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

    Authors: Chad E. Mire, Robert W. Cross, Joan B. Geisbert, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Megan L. Heinrich, Megan M. Rowland, Augustine Goba, Mambu Momoh, Matthew L. Boisen, Donald S. Grant, Mohamed Fullah, Sheik Humarr Khan, Karla A. Fenton, James E. Robinson, Luis M. Branco, Robert F. Garry, Thomas W. Geisbert - Nature Medicine 2017 cited by 141

  19. Current state of Ebola virus vaccines: A snapshot

    Authors: Courtney Woolsey, Thomas W. Geisbert - PLoS Pathogens 2021 cited by 119

  20. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

    Authors: Ha V. Dang, Robert W. Cross, Viktoriya Borisevich, Zachary A. Bornholdt, Brandyn R. West, Yee‐Peng Chan, Chad E. Mire, Sofia Cheliout Da Silva, Antony S. Dimitrov, Lianying Yan, Moushimi Amaya, Chanakha K. Navaratnarajah, Larry Zeitlin, Thomas W. Geisbert, Christopher C. Broder, David Veesler - Nature Structural & Molecular Biology 2021 cited by 77

  21. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection

    Authors: Chad E. Mire, Yee‐Peng Chan, Viktoriya Borisevich, Robert W. Cross, Lianying Yan, Krystle N. Agans, Ha V. Dang, David Veesler, Karla A. Fenton, Thomas W. Geisbert, Christopher C. Broder - The Journal of Infectious Diseases 2019 cited by 78

  22. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein

    Authors: Michael P. Doyle, Nurgun Kose, Viktoriya Borisevich, Elad Binshtein, Moushimi Amaya, Marcus Nagel, Edward J. Annand, Erica Armstrong, Robin Bombardi, Jinhui Dong, Kevin L. Schey, Christopher C. Broder, Larry Zeitlin, Erin A. Kuang, Zachary A. Bornholdt, Brandyn R. West, Thomas W. Geisbert, Robert W. Cross, James E. Crowe - Cell Reports 2021 cited by 49

  23. Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease

    Authors: Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Courtney Woolsey, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Dafna M. Abelson, Do H. Kim, William S. Shestowsky, Lioudmila A. Campbell, Elaine Bunyan, Joan B. Geisbert, Natalie S. Dobias, Karla A. Fenton, Danielle Porter, Larry Zeitlin, Thomas W. Geisbert - JCI Insight 2022 cited by 44

  24. Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus

    Authors: Robert W. Cross, Courtney Woolsey, Victor C. Chu, Darius Babusis, Roy Bannister, Meghan S. Vermillion, Romas Geleziunas, Kimberly T. Barrett, Elaine Bunyan, Anh-Quan Nguyen, Tomáš Cihlář, Danielle Porter, Abhishek N. Prasad, Daniel J. Deer, Viktoriya Borisevich, Krystle N. Agans, Jasmine Martinez, Mack B. Harrison, Natalie S. Dobias, Karla A. Fenton, John P. Bilello, Thomas W. Geisbert - Science 2024 cited by 36